Published in Int J Cancer on November 01, 2003
Overexpression of cathepsin F, matrix metalloproteinases 11 and 12 in cervical cancer. BMC Cancer (2005) 1.09
Investigation of the molecular profile of basal cell carcinoma using whole genome microarrays. Mol Cancer (2006) 0.98
Cancer diagnosis marker extraction for soft tissue sarcomas based on gene expression profiling data by using projective adaptive resonance theory (PART) filtering method. BMC Bioinformatics (2006) 0.89
Clinicopathological significance of stromal variables: angiogenesis, lymphangiogenesis, inflammatory infiltration, MMP and PINCH in colorectal carcinomas. Mol Cancer (2006) 0.86
Significance of MMP11 and P14(ARF) expressions in clinical outcomes of patients with laryngeal cancer. Int J Clin Exp Med (2015) 0.84
Serum levels of MMP-11 correlate with clinical outcome in Chinese patients with advanced gastric adenocarcinoma. BMC Cancer (2011) 0.83
Study of matrix metalloproteinases and their inhibitors in prostate cancer. Br J Cancer (2010) 0.79
Effect of the expression of matrix metalloproteases and their tissue inhibitors on survival of patients with resectable colorectal cancer. Dig Dis Sci (2012) 0.78
High level of plasma matrix metalloproteinase-11 is associated with clinicopathological characteristics in patients with oral squamous cell carcinoma. PLoS One (2014) 0.77
Altered gene expression in conjunctival squamous cell carcinoma. Mod Pathol (2016) 0.76
Methanol and Butanol Extracts of Paeonia lutea Leaves Repress Metastasis of Squamous Cell Carcinoma. Evid Based Complement Alternat Med (2016) 0.75
Any defining role of mast cell or mast cell density in oral squamous cell carcinoma? Ann Med Health Sci Res (2014) 0.75
Osteoactivin regulates head and neck squamous cell carcinoma invasion by modulating matrix metalloproteases. J Cell Physiol (2017) 0.75
Celiac disease with mild to moderate histologic changes is a common cause of chronic diarrhea in Indian children. J Pediatr Gastroenterol Nutr (2005) 2.53
Clinical features and prognostic factors of early breast cancer at a major cancer center in North India. Indian J Cancer (2005) 1.48
Pre and post eradication gastric inflammation in Helicobacter pylori-associated duodenal ulcer. Indian J Gastroenterol (2002) 1.41
Identification of differentially expressed genes in oral squamous cell carcinoma. Mol Carcinog (2005) 1.36
Expression analysis of E-cadherin, Slug and GSK3beta in invasive ductal carcinoma of breast. BMC Cancer (2009) 1.29
Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients. Life Sci (2007) 1.20
Curcumin down regulates smokeless tobacco-induced NF-kappaB activation and COX-2 expression in human oral premalignant and cancer cells. Toxicology (2006) 1.18
Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients. Life Sci (2007) 1.17
Overview of current and future biologically based targeted therapies in head and neck squamous cell carcinoma. Head Neck Oncol (2009) 1.16
Guggulsterone, a farnesoid X receptor antagonist, inhibits constitutive and inducible STAT3 activation through induction of a protein tyrosine phosphatase SHP-1. Cancer Res (2008) 1.14
Over-expression of 14-3-3zeta is an early event in oral cancer. BMC Cancer (2007) 1.09
MEMD/ALCAM: a potential marker for tumor invasion and nodal metastasis in esophageal squamous cell carcinoma. Oncology (2005) 1.07
Frequent loss of Dab2 protein and infrequent promoter hypermethylation in breast cancer. Breast Cancer Res Treat (2006) 1.06
Wnt signaling pathway in invasive ductal carcinoma of the breast: relationship between beta-catenin, dishevelled and cyclin D1 expression. Oncology (2008) 1.06
Nuclear S100A7 is associated with poor prognosis in head and neck cancer. PLoS One (2010) 1.04
Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients. Life Sci (2010) 1.04
A rare case of giant leiomyosarcoma in a filarial scrotum: a case report. World J Surg Oncol (2011) 1.03
Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India. Breast Cancer Res Treat (2004) 1.03
Heterogeneous ribonucleoprotein K is a marker of oral leukoplakia and correlates with poor prognosis of squamous cell carcinoma. Int J Cancer (2009) 1.03
Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast. Life Sci (2008) 1.03
Sentinel lymph node biopsy assessment using intraoperative imprint cytology in breast cancer patients: results of a validation study. Asian J Surg (2004) 1.02
Complete response from thalidomide in angiosarcoma after treatment of breast cancer. J Clin Oncol (2007) 1.02
Clinical significance of altered expression of β-catenin and E-cadherin in oral dysplasia and cancer: potential link with ALCAM expression. PLoS One (2013) 1.02
Angiogenesis in cutaneous melanoma: pathogenesis and clinical implications. Microsc Res Tech (2003) 1.02
Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis. Clin Cancer Res (2005) 1.01
Expression of DNA methyltransferases in breast cancer patients and to analyze the effect of natural compounds on DNA methyltransferases and associated proteins. J Breast Cancer (2013) 1.01
Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry. J Proteome Res (2008) 1.00
Stromelysin-2 overexpression in human esophageal squamous cell carcinoma: potential clinical implications. Cancer Detect Prev (2002) 0.99
Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/beta-catenin signaling. Chem Biol Interact (2009) 0.99
S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia. Int J Cancer (2013) 0.99
Hepatocellular carcinoma in a hepatitis B 'x' transgenic mouse model: A sequential pathological evaluation. J Gastroenterol Hepatol (2003) 0.99
Detection of RASSF1A and RARbeta hypermethylation in serum DNA from breast cancer patients. Epigenetics (2006) 0.97
Novel germline mutations in the BRCA1 and BRCA2 genes in Indian breast and breast-ovarian cancer families. Hum Mutat (2004) 0.97
Xanthogranulomatous pancreatitis: mass lesion of the pancreas simulating pancreatic carcinoma--a report of two cases. Indian J Pathol Microbiol (2004) 0.97
14-3-3 zeta as novel molecular target for cancer therapy. Expert Opin Ther Targets (2012) 0.96
Prognostic relevance of promoter hypermethylation of multiple genes in breast cancer patients. Cell Oncol (2009) 0.96
Randomized trial comparing neo-adjuvant versus adjuvant chemotherapy in operable locally advanced breast cancer (T4b N0-2 M0). J Surg Oncol (2003) 0.96
Surgical management of skin cancers: experience from a regional cancer centre in North India. Indian J Cancer (2005) 0.95
Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma. Oncology (2005) 0.94
Small interfering RNA targeting 14-3-3ζ increases efficacy of chemotherapeutic agents in head and neck cancer cells. Mol Cancer Ther (2010) 0.94
CpG hypomethylation of MDR1 gene in tumor and serum of invasive ductal breast carcinoma patients. Clin Biochem (2009) 0.94
Ets-1 and VEGF expression correlates with tumor angiogenesis, lymph node metastasis, and patient survival in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol (2003) 0.93
Expression of NF-kappaB parallels COX-2 expression in oral precancer and cancer: association with smokeless tobacco. Int J Cancer (2007) 0.93
Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers. Head Neck (2004) 0.93
A rare case of gallbladder carcinoma metastases to the breast treated with curative intent. Trop Gastroenterol (2012) 0.92
Cytoplasmic accumulation of activated leukocyte cell adhesion molecule is a predictor of disease progression and reduced survival in oral cancer patients. Int J Cancer (2009) 0.92
Differential expression of G-protein coupled receptor 56 in human esophageal squamous cell carcinoma. Cancer Lett (2006) 0.92
Promoter hypermethylation in Indian primary oral squamous cell carcinoma. Int J Cancer (2010) 0.92
Prognostic significance of nuclear pSTAT3 in oral cancer. Head Neck (2011) 0.91
Clinical significance of Maspin promoter methylation and loss of its protein expression in invasive ductal breast carcinoma: correlation with VEGF-A and MTA1 expression. Tumour Biol (2010) 0.91
Transglutaminase 2 overexpression in tumor stroma identifies invasive ductal carcinomas of breast at high risk of recurrence. PLoS One (2013) 0.90
Discovery of deregulation of zinc homeostasis and its associated genes in esophageal squamous cell carcinoma using cDNA microarray. Int J Cancer (2007) 0.90
Demethylating agent 5-aza-2-deoxycytidine enhances susceptibility of breast cancer cells to anticancer agents. Mol Cell Biochem (2010) 0.89
Clinical significance of GPR56, transglutaminase 2, and NF-κB in esophageal squamous cell carcinoma. Cancer Invest (2010) 0.89
Population-based incidence of intussusception and a case-control study to examine the association of intussusception with natural rotavirus infection among indian children. J Infect Dis (2009) 0.89
Overexpression of prothymosin alpha predicts poor disease outcome in head and neck cancer. PLoS One (2011) 0.89
An Ep-ICD based index is a marker of aggressiveness and poor prognosis in thyroid carcinoma. PLoS One (2012) 0.88
DNA methylation of circulating DNA: a marker for monitoring efficacy of neoadjuvant chemotherapy in breast cancer patients. Tumour Biol (2012) 0.88
14-3-3 zeta is a molecular target in guggulsterone induced apoptosis in head and neck cancer cells. BMC Cancer (2010) 0.88
TC21/R-Ras2 upregulation in esophageal tumorigenesis: potential diagnostic implications. Oncology (2005) 0.87
Clinical significance of TC21 overexpression in oral cancer. J Oral Pathol Med (2009) 0.87
Guggulsterone (GS) inhibits smokeless tobacco and nicotine-induced NF-κB and STAT3 pathways in head and neck cancer cells. Carcinogenesis (2010) 0.86
Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma. BMC Cancer (2012) 0.86
Clinical significance of sperm protein 17 expression and immunogenicity in esophageal cancer. Int J Cancer (2007) 0.86
Significance of promoter hypermethylation of p16 gene for margin assessment in carcinoma tongue. Head Neck (2009) 0.86
Establishment and characterization of a cell line from smokeless tobacco associated oral squamous cell carcinoma. Oral Oncol (2003) 0.85
Secretome-based identification and characterization of potential biomarkers in thyroid cancer. J Proteome Res (2010) 0.85
Clinical significance of Stratifin, ERalpha and PR promoter methylation in tumor and serum DNA in Indian breast cancer patients. Clin Biochem (2009) 0.84
MGMT expression in oral precancerous and cancerous lesions: correlation with progression, nodal metastasis and poor prognosis. Oral Oncol (2006) 0.84
Intraoperative neck staging using sentinel node biopsy and imprint cytology in oral cancer. Head Neck (2003) 0.84
Clinical significance of promoter hypermethylation of ERβ and RARβ2 in tumor and serum DNA in Indian breast cancer patients. Ann Surg Oncol (2012) 0.84
BRCA1 germline mutations in Indian familial breast cancer. Hum Mutat (2003) 0.84
Myocutaneous versus thoraco-abdominal flap cover for soft tissue defects following surgery for locally advanced and recurrent breast cancer. J Surg Oncol (2003) 0.84
Differential expression of retinoic acid receptors in normal and malignant esophageal tissues. J Exp Ther Oncol (2004) 0.83
Smokeless tobacco (khaini) extracts modulate gene expression in epithelial cell culture from an oral hyperplasia. Oral Oncol (2005) 0.83
Updates on the multimodality management of desmoplastic small round cell tumor. J Surg Oncol (2012) 0.83
Transcriptional gene expression profile of human esophageal squamous cell carcinoma. Genomics (2003) 0.83
Novel molecular targets of smokeless tobacco (khaini) in cell culture from oral hyperplasia. Toxicology (2006) 0.82
Expression analysis of maspin in invasive ductal carcinoma of breast and modulation of its expression by curcumin in breast cancer cell lines. Chem Biol Interact (2009) 0.82
An unusual presentation of a malignant jejunal tumor and a different management strategy. World J Surg Oncol (2005) 0.82
Patient profile and treatment outcome of rectal cancer patients treated with multimodality therapy at a regional cancer center. Indian J Cancer (2004) 0.82
Sperm protein 17 is a novel marker for predicting cisplatin response in esophageal squamous cancer cell lines. Int J Cancer (2010) 0.81
A sensitive test for the detection of specific DSB repair defects in primary cells from breast cancer specimens. Int J Cancer (2008) 0.81
siRNA-mediated downregulation of TC21 sensitizes esophageal cancer cells to cisplatin. World J Gastroenterol (2012) 0.80
Soluble and membranous vascular endothelial growth factor receptor-2 in pregnancies complicated by pre-eclampsia. Yonsei Med J (2009) 0.80
Prognostic significance of stromelysin-3 and tissue inhibitor of matrix metalloproteinase-2 in esophageal cancer. Oncology (2004) 0.80
Microscopic colitis in children with chronic diarrhea. J Pediatr Gastroenterol Nutr (2013) 0.79